BCTXW - BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences | Benzinga
PHILADELPHIA and VANCOUVER, British Columbia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW)) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that BriaCell will be presenting at the following two upcoming scientific conferences.
The 2023 SITC 38th Annual Meeting will be taking place November 3-5, 2023 at San Diego Convention Center, San Diego, CA.
Abstract Title: Development and Mechanism of Action of a Novel Cellular Immunotherapeutic Platform for the Treatment of Cancer
Abstract Number: 419
Session Date and Time: Friday November 3, 2023 9:00 AM - 6:00 PM
The 2023 San Antonio Breast Cancer Symposium® will be taking place December 5-9, 2023 at Henry B. Gonzalez Convention Center, San Antonio, TX.
Poster 1:
Abstract Title: CD8+ Tumor Infiltrating Lymphocytes Turn a Cold Tumor Hot in Metastatic Breast Cancer
Submission ID: 1577766
Presentation ID: PO1-20-12
Spotlight Session: Poster Session 1
Session Date and Time: Wednesday December 6, 2023 12:00 PM - 2:00 PM
Poster 2:
Abstract Title: Analysis of Antibody Response to SV-BR-1-GM Therapeutic Vaccine in Breast Cancer Patients Using Human Protein Microarrays: Potential Correlations with ...